These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 6437780)
1. Captopril: pharmacology, metabolism and disposition. Migdalof BH; Antonaccio MJ; McKinstry DN; Singhvi SM; Lan SJ; Egli P; Kripalani KJ Drug Metab Rev; 1984; 15(4):841-69. PubMed ID: 6437780 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [TBL] [Abstract][Full Text] [Related]
3. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels. Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882 [TBL] [Abstract][Full Text] [Related]
5. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics. Chan PS; Ronsberg MA; Cervoni P Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition with quinapril (CI-906) and captopril in spontaneously hypertensive rats with suppressed renin-angiotensin system. Säynävälammi P; Pörsti I Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):325-31. PubMed ID: 3309510 [TBL] [Abstract][Full Text] [Related]
7. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping. Bing RF; Russell GI; Swales JD; Thurston H J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368 [TBL] [Abstract][Full Text] [Related]
8. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system. Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343 [TBL] [Abstract][Full Text] [Related]
9. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
10. [Captopril - profile of a new antihypertensive (author's transl)]. Gross F MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855 [TBL] [Abstract][Full Text] [Related]
11. Effects of captopril on the development of tolerance to guanethidine. Rankin GO; Haas GJ Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227 [TBL] [Abstract][Full Text] [Related]
12. [Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)]. Levenson J; Simon A; Temmar M; Safar M Nouv Presse Med; 1980 Feb; 9(9):617-9. PubMed ID: 6987622 [TBL] [Abstract][Full Text] [Related]
13. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension. Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083 [TBL] [Abstract][Full Text] [Related]
14. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390 [TBL] [Abstract][Full Text] [Related]
16. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)]. Goto A Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093 [TBL] [Abstract][Full Text] [Related]
17. Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T Arzneimittelforschung; 1985; 35(10):1502-7. PubMed ID: 3000389 [TBL] [Abstract][Full Text] [Related]
18. Blood pressure regulation by angiotensin in the spontaneously hypertensive rats. Sokabe H; Kawashima K; Watanabe TX Adv Exp Med Biol; 1979; 120B():429-35. PubMed ID: 390989 [TBL] [Abstract][Full Text] [Related]
19. Effect of Cydonia oblonga Mill. leaf extracts or captopril on blood pressure and related biomarkers in renal hypertensive rats. Zhou WT; Abdurahman A; Abdusalam E; Yiming W; Abliz P; Aji Q; Issak M; Iskandar G; Moore N; Umar A J Ethnopharmacol; 2014 May; 153(3):635-40. PubMed ID: 24661965 [TBL] [Abstract][Full Text] [Related]
20. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients. Giudicelli JF; Chaignon M; Richer C; Giroux B; Guedon J Br J Clin Pharmacol; 1984 Nov; 18(5):749-58. PubMed ID: 6095887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]